Living Medical
Textbook
From Projects In Knowledge
Osteoporosis
Fracture Prevention and Therapeutic Management Edition
Table of Contents
|
CME/CE Information
|
Technical Requirements
|
Login
Chapter 1
Overview of Osteoporosis
Last Reviewed: May 20, 2010
Chapter 2
Identifying Patients at Risk for Osteoporosis and Fractures
Last Reviewed: May 20, 2010
Chapter 3
Assessment of Fracture Risk Using FRAX
®
Last Reviewed: May 20, 2010
Chapter 4
Treatment of Osteoporosis
Last Reviewed: May 20, 2010
–
Introduction/Pharmacologic Interventions
–
Antiresorptive/Anabolic Therapy
–
Emerging Therapies
–
Nonpharmacologic Interventions/Nutrition
–
Physical Activity
–
Fall Prevention/Tobacco Avoidance/Moderate Alcohol Consumption
–
Conclusion
–
References
Chapter 5
Management of the Postfracture Patient
Last Reviewed: May 20, 2010
Chapter 6
Monitoring
Last Reviewed: May 20, 2010
/1892/images/PIKEduInit.gif [NO]
This activity is supported by an educational donation provided by
Amgen
.
/1892/iPhoneAd/1892iPhoneAd.gif [NO]
Osteoporosis News powered by
This CME program will include a brief pretest. Please start now by answering these 3 questions:
1.
Which of the following drugs is not approved for the treatment of osteoporosis in postmenopausal women?
*
Salmon calcitonin
Estrogen
Teriparatide
Intravenous ibandronate
2.
Among the following patients, who is the best candidate for anabolic therapy with teriparatide?
*
A postmenopausal woman who is treatment-naive for a bone active agent and without prevalent fracture
A postmenopausal woman who experienced a fragility fracture despite an increase in bone mineral density on bisphosphonate treatment
A premenopausal woman with osteopenia
A postmenopausal woman who had therapeutic skeletal radiation 10 years prior
3.
Ms P, a 60-year-old postmenopausal woman, typically consumes per day one 6-ounce container of yogurt, one 8-ounce glass of milk, no cheese or calcium-fortified juices or foods, and a reasonable number of fruits and vegetables. How much calcium should she receive in supplemental form, if any, to meet the threshold recommended by the National Osteoporosis Foundation?
*
None
1200 mg
350 mg to 650 mg
650 mg to 850 mg